Acquired EGFR resistant mutations in non-small cell lung cancer (NSCLC) | Caris Life Sciences
Home / Research / Publications / Acquired EGFR resistant mutations in non-small cell lung cancer (NSCLC)

Publications

Acquired EGFR resistant mutations in non-small cell lung cancer (NSCLC)

Key Finding:

Acquired EGFR resistance mutations are heterogenous, but their frequency remains low, likely due to limited sequencing of EGFR resistant non-small cell lung cancers. 

Download Publication
Learn More
Name(Required)